These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 16632614

  • 1. Commentary: PET poised to alter the current paradigm for response assessment of non-Hodgkin's lymphoma.
    Guermazi A, Juweid ME.
    Br J Radiol; 2006 May; 79(941):365-7. PubMed ID: 16632614
    [No Abstract] [Full Text] [Related]

  • 2. Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma.
    Wirth A, Seymour JF, Hicks RJ, Ware R, Fisher R, Prince M, MacManus MP, Ryan G, Januszewicz H, Wolf M.
    Am J Med; 2002 Mar; 112(4):262-8. PubMed ID: 11893364
    [Abstract] [Full Text] [Related]

  • 3. Expert opinions on positron emission tomography and computed tomography imaging in lymphoma.
    Delbeke D, Stroobants S, de Kerviler E, Gisselbrecht C, Meignan M, Conti PS.
    Oncologist; 2009 Mar; 14 Suppl 2():30-40. PubMed ID: 19819922
    [Abstract] [Full Text] [Related]

  • 4. Hodgkin's and non-Hodgkin's lymphomas.
    Rademaker J.
    Radiol Clin North Am; 2007 Jan; 45(1):69-83. PubMed ID: 17157624
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical value of FDG PET using coincident gamma cameras in staging and restaging of malignant lymphoma--compared with convenitonal diagnostic methods].
    Pichler R, Maschek W, Hatzl-Griesenhofer M, Huber H, Wimmer G, Wahl G, Fridrik M.
    Nuklearmedizin; 2000 Sep; 39(6):166-73. PubMed ID: 11057408
    [Abstract] [Full Text] [Related]

  • 7. Aggressive and indolent non-Hodgkin's lymphoma: response assessment by integrated international workshop criteria.
    Brepoels L, Stroobants S, De Wever W, Spaepen K, Vandenberghe P, Thomas J, Uyttebroeck A, Mortelmans L, De Wolf-Peeters C, Verhoef G.
    Leuk Lymphoma; 2007 Aug; 48(8):1522-30. PubMed ID: 17701583
    [Abstract] [Full Text] [Related]

  • 8. New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma.
    Cheson BD.
    Radiol Clin North Am; 2008 Mar; 46(2):213-23, vii. PubMed ID: 18619377
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The use of positron emission tomography with [18F] 2-fluoro-D-2-deoxyglucose (FDG-PET) in Hodgkin and non-Hodgkin's lymphoma.
    Chiusolo P, Sica S, Leone G.
    Hematology; 2003 Dec; 8(6):403-8. PubMed ID: 14668036
    [Abstract] [Full Text] [Related]

  • 11. [End of treatment evaluation in patients with aggressive non-Hodgkin's lymphoma].
    Warland V, Jérusalem G, Hustinx R, Beguin Y, Silvestre RM, Fassotte MF, Foidart-Willems J, Fillet G.
    Rev Med Liege; 2002 Dec; 57(12):779-84. PubMed ID: 12632835
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 18F-FDG PET as a routine test for posttherapy assessment of Hodgkin's disease and aggressive non-Hodgkin's lymphoma: where is the evidence?
    Juweid ME.
    J Nucl Med; 2008 Jan; 49(1):9-12. PubMed ID: 18077522
    [No Abstract] [Full Text] [Related]

  • 14. Response assessment in lymphoma.
    Hampson FA, Shaw AS.
    Clin Radiol; 2008 Feb; 63(2):125-35. PubMed ID: 18194687
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of response to fractionated radioimmunotherapy with 90Y-epratuzumab in non-Hodgkin's lymphoma by 18F-fluorodeoxyglucose positron emission tomography.
    Bodet-Milin C, Kraeber-Bodéré F, Dupas B, Morschhauser F, Gastinne T, Le Gouill S, Campion L, Harousseau JL, Wegener WA, Goldenberg DM, Huglo D.
    Haematologica; 2008 Mar; 93(3):390-7. PubMed ID: 18268287
    [Abstract] [Full Text] [Related]

  • 16. FDG-PET in 10 children with non-Hodgkin's lymphoma: initial experience in staging and follow-up.
    Amthauer H, Furth C, Denecke T, Hundsdoerfer P, Voelker T, Seeger K, Stöver B, Henze G.
    Klin Padiatr; 2005 Mar; 217(6):327-33. PubMed ID: 16307418
    [Abstract] [Full Text] [Related]

  • 17. Fluorine-18 fluorodeoxyglucose positron emission tomography for lymphoma: incorporating new technology into clinical care.
    Kaplan LD.
    Am J Med; 2002 Mar; 112(4):320-1. PubMed ID: 11893374
    [No Abstract] [Full Text] [Related]

  • 18. [Value of positron emission tomography in treatment of lymphoma patients].
    Kuwert T.
    Strahlenther Onkol; 2001 Mar; 177(3):160-1. PubMed ID: 11285774
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
    Shen YY, Kao A, Yen RF.
    Oncol Rep; 2002 Mar; 9(2):321-5. PubMed ID: 11836600
    [Abstract] [Full Text] [Related]

  • 20. Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease.
    Even-Sapir E, Lievshitz G, Perry C, Herishanu Y, Lerman H, Metser U.
    Radiol Clin North Am; 2007 Jul; 45(4):697-709, vii. PubMed ID: 17706534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.